Alkem Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
February 09, 2024 at 02:47 am EST
Share
Alkem Laboratories Limited reported earnings results for the third quarter and nine months ended December 31, 2023. For the third quarter, the company reported sales was INR 33,238.7 million compared to INR 30,409.1 million a year ago. Revenue was INR 34,175.1 million compared to INR 30,862.4 million a year ago. Net income was INR 5,949.6 million compared to INR 4,547.1 million a year ago. Basic earnings per share from continuing operations was INR 49.76 compared to INR 38.03 a year ago. Diluted earnings per share from continuing operations was INR 49.76 compared to INR 38.03 a year ago.
For the nine months, sales was INR 97,317.6 million compared to INR 86,966.6 million a year ago. Revenue was INR 99,544.3 million compared to INR 88,440.7 million a year ago. Net income was INR 15,022.1 million compared to INR 9,131.9 million a year ago. Basic earnings per share from continuing operations was INR 125.64 compared to INR 76.38 a year ago. Diluted earnings per share from continuing operations was INR 125.64 compared to INR 76.38 a year ago.
Alkem Laboratories Limited is an India-based company, which is engaged in the pharmaceutical business with global operations. The Company is engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products. The Company offers its products across various therapeutic areas, such as Anti Infective, Dermatology, Diabetology, Cardiology, Gastroenterology, Osteoporosis, Rheumatology, central nervous system (CNS), Oncology, Urology, Gynecology, and Vitamins, Mineral and Nutrition. Its product range includes Rx Products, Alkem Generics and OTC Product. The Companyâs product portfolio includes brands, such as Clavam, Pan, Pan-D, Taxim-O, A To Z NS, Xone, Taxim, Gemcal, Pipzo and Ondem. The Company operates through a segment, Pharmaceuticals. It has approximately 21 manufacturing facilities at multiple locations in India and the United States. The Company has approximately 800 brands and operates in 40 countries.